Geneos Wealth Management’s Nutrien NTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $40.4K | Sell |
642
-81
| -11% | -$5.66K | ﹤0.01% | 1537 |
|
|
2026
Q1 | $54.6K | Buy |
723
+130
| +22% | +$9.27K | ﹤0.01% | 1386 |
|
|
2025
Q4 | $36.6K | Hold |
593
| – | – | ﹤0.01% | 1509 |
|
|
2025
Q3 | $34.8K | Sell |
593
-142
| -19% | -$8.28K | ﹤0.01% | 1515 |
|
|
2025
Q2 | $42.8K | Buy |
735
+219
| +42% | +$12.4K | ﹤0.01% | 1655 |
|
|
2025
Q1 | $25.6K | Buy |
516
+42
| +9% | +$2.15K | ﹤0.01% | 1826 |
|
|
2024
Q4 | $21.2K | Sell |
474
-450
| -49% | -$21.4K | ﹤0.01% | 1701 |
|
|
2024
Q3 | $44.4K | Sell |
924
-76
| -8% | -$3.66K | ﹤0.01% | 1242 |
|
|
2024
Q2 | $50.9K | Hold |
1,000
| – | – | ﹤0.01% | 1063 |
|
|
2024
Q1 | $54.3K | Sell |
1,000
-690
| -41% | -$36K | ﹤0.01% | 1034 |
|
|
2023
Q4 | $95.2K | Sell |
1,690
-800
| -32% | -$45.2K | ﹤0.01% | 853 |
|
|
2023
Q3 | $154K | Sell |
2,490
-100
| -4% | -$6.33K | 0.01% | 750 |
|
|
2023
Q2 | $153K | Hold |
2,590
| – | – | 0.01% | 751 |
|
|
2023
Q1 | $191K | Buy |
2,590
+319
| +14% | +$24.6K | 0.01% | 660 |
|
|
2022
Q4 | $166K | Hold |
2,271
| – | – | 0.01% | 689 |
|
|
2022
Q3 | $189K | Sell |
2,271
-1,061
| -32% | -$91.3K | 0.01% | 615 |
|
|
2022
Q2 | $263K | Sell |
3,332
-378
| -10% | -$36.7K | 0.01% | 656 |
|
|
2022
Q1 | $385K | Sell |
3,710
-654
| -15% | -$54.2K | 0.02% | 609 |
|
|
2021
Q4 | $328K | Sell |
4,364
-122
| -3% | -$8.54K | 0.01% | 702 |
|
|
2021
Q3 | $300K | Sell |
4,486
-120
| -3% | -$7.34K | 0.01% | 714 |
|
|
2021
Q2 | $279K | Sell |
4,606
-277
| -6% | -$16.4K | 0.01% | 719 |
|
|
2021
Q1 | $269K | Buy |
4,883
+1
| +0% | +$54 | 0.01% | 846 |
|
|
2020
Q4 | $271K | Buy |
4,882
+1,335
| +38% | +$59K | 0.01% | 721 |
|
|
2020
Q3 | $140K | Sell |
3,547
-127
| -3% | -$4.62K | 0.01% | 811 |
|
|
2020
Q2 | $120K | Sell |
3,674
-277
| -7% | -$9.64K | 0.01% | 835 |
|
|
2020
Q1 | $122K | Buy |
3,951
+1
| +0% | +$40 | 0.01% | 772 |
|
|
2019
Q4 | $189K | Sell |
3,950
-322
| -8% | -$15.6K | 0.01% | 714 |
|
|
2019
Q3 | $211K | Sell |
4,272
-1,123
| -21% | -$57.3K | 0.01% | 646 |
|
|
2019
Q2 | $289K | Sell |
5,395
-574
| -10% | -$30K | 0.02% | 556 |
|
|
2019
Q1 | $314K | Buy |
5,969
+282
| +5% | +$14.7K | 0.02% | 517 |
|
|
2018
Q4 | $263K | Sell |
5,687
-817
| -13% | -$42.6K | 0.02% | 520 |
|
|
2018
Q3 | $375K | Buy |
6,504
+263
| +4% | +$14.6K | 0.03% | 450 |
|
|
2018
Q2 | $339K | Sell |
6,241
-236
| -4% | -$11.7K | 0.03% | 407 |
|
|
2018
Q1 | $305K | Buy |
+6,477
| New | +$324K | 0.03% | 414 |
|
Other funds holding NTR
Geneos Wealth Management's NTR Position: Q2 2026 in Review
Geneos Wealth Management reduced its Nutrien (NTR) stake by 11% in Q2 2026, selling an estimated $5.66K and leaving 642 shares worth $40.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1537.
Geneos Wealth Management first reported a position in NTR in Q1 2018 and has held it in 34 quarters since. The position peaked at $385K in Q1 2022. 733 funds tracked by Wall St. Rank hold NTR as of Q2 2026.
- Geneos Wealth Management held 642 shares of Nutrien worth $40.4K as of Q2 2026.
- Geneos Wealth Management sold 81 Nutrien shares in Q2 2026, an estimated $5.66K.
- Nutrien made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1537 holding.
- Geneos Wealth Management first reported a position in Nutrien in Q1 2018 and has held it in 34 quarters since.
- Geneos Wealth Management's Nutrien position peaked at $385K in Q1 2022.
- 733 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.